CIBC Bancorp USA’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$492K Buy
9,381
+1,136
+14% +$44.4K ﹤0.01% 1316
2026
Q1
$292K Buy
+8,245
New +$256K ﹤0.01% 1436
2025
Q3
$519K Buy
+17,296
New +$488K ﹤0.01% 854

Other funds holding ALKS

CIBC Bancorp USA's ALKS Position: Q2 2026 in Review

CIBC Bancorp USA increased its Alkermes (ALKS) stake by 14% in Q2 2026, buying an estimated $44.4K and bringing the position to 9,381 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

CIBC Bancorp USA first reported a position in ALKS in Q3 2025 and has held it in 3 quarters since. The position peaked at $519K in Q3 2025. 395 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • CIBC Bancorp USA held 9,381 shares of Alkermes worth $492K as of Q2 2026.
  • CIBC Bancorp USA bought 1,136 Alkermes shares in Q2 2026, an estimated $44.4K.
  • Alkermes made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1316 holding.
  • CIBC Bancorp USA first reported a position in Alkermes in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Alkermes position peaked at $519K in Q3 2025.
  • 395 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.